KCRS24 Leadership Committee

TONI CHOUEIRI, MD

COMMITTEE CO-CHAIR

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

HANS HAMMERS, MD, PhD

COMMITTEE CO-CHAIR

UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

ARI HAKIMI, MD, PhD

Memorial Sloan Kettering Cancer Center
Associate Professor

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine and Urology

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Director, Lead for Solid Tumour Research

BRYAN LEWIS

KidneyCAN
President

SUSAN POTEAT

KidneyCAN
Medical Science Liaison

Abstract Committee

ALEXANDER CHEHRAZI-RAFFLE, MD

City of Hope Comprehensive Cancer Center
Assistant Professor

Yu-Wei Chen, MD, MS

University of California, San Diego
Assistant Professor

SCOTT HAAKE, MD

Vanderbilt University Medical Center
Associate Professor

BRANDON MANLEY, MD

Moffitt Cancer Center
Urologic Oncologist

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine and Urology

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

EVITA SADIMIN, MD

City of Hope Comprehensive Cancer Center
Associate Clinical Professor

YUKSEL URUN, MD

Ankara University School of Medicine
Professor of Medicine

YOUSEF ZAKHARIA, MD

Holden Comprehensive Cancer Center
Medical Oncologist

DoD / KCRP Session Committee

KATY BECKERMANN, MD, PhD

Vanderbilt University Medical Center
Assistant Professor

ERIC JONASCH, MD

MD Anderson Cancer Center
Professor, Department of Genitourinary Medical Oncology

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Center
Assistant Professor

SCOTT TYKODI, MD PhD

Fred Hutchinson Cancer Center
Assistant Professor

Communications Committee

NEERAJ AGARWAL, MD

Huntsman Cancer Institute
Senior Director of Clinical Research Innovation

CRISTIANE BERGEROT, PhD

Head of the Psycho-Oncology Department
Centro de Câncer de Brasília

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

NAZLI DIZMAN, MD

MD Anderson Cancer Center
Fellow

GIL MORGAN, MD

Skane University Hospital
Medical Oncologist

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Center
Assistant Professor, Department of Genitourinary Medical Oncology

RENEE MARIA SALIBY, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

FABIO SCHUTZ, MD

BP – A Beneficencia, Portuguesa de Sao Paulo
Oncologista Clinico

MICHAEL SERZAN, MD

Dana-Farber Cancer Institute
Medical Oncologist

YUKSEL URUN, MD

Ankara University School of Medicine
Professor of Medicine

QING ZHANG, PhD

UT Southwestern Medical Center
Associate Professor

TIAN ZHANG, MD

UT Southwestern Medical Center
Associate Professor

ADRIAN HAYES

KidneyCAN
Communications Consultant

pre-meeting

RCC Perioperative Trial Collaborative (RCC-PTC)

Closed Session – Invitation only for Collaborative Members

MODERATORS

AXEL BEX, MD, PhD

Royal Free London Hospital
Clinical Lead Consultant Specialist Centre for Kidney Cancer

GRANT STEWART, MBChB, PhD

University of Cambridge
Professor of Surgical Oncology

kcrs24 day one

Keynote: How the Air We Breathe Can Impact Cancer

KEYNOTE SPEAKER

CHARLES SWANTON, FRCP, BSc, PhD

The Francis Crick Institute
Deputy Clinical Director, Cancer Evolution and Genome Instability Laboratory

session 1

Exploring Novel Drug Targets for RCC

MODERATORS

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Center
Assistant Professor

SCOTT TYKODI, MD PhD

Fred Hutchinson Cancer Center
Assistant Professor

speakers

JEAN JIANG, PhD

University of Texas Health San Antonio
Professor

ELIZABETH HENSKE, MD

Brigham & Women’s Hospital/Harvard Medical School
Professor

ABHISHEK CHAKRABORTY, PhD

Cleveland Clinic Foundation
Assistant Professor

NEIL BHOWMICK, PhD

Cedars-Sinai Medical Center
Professor of Medicine

session 2

Novel Imaging and Biomarkers to Guide RCC Patient Management

MODERATORS

STEPHANIE A BERG, DO

Dana-Farber Cancer Institute

KATY BECKERMANN, MD, PhD

Vanderbilt University Medical Center
Assistant Professor

SPEAKERS

XIANKAI SUN, PhD

University of Texas Southwestern Medical Center
Professor

JEREMIAH MORRISSEY, PhD

Washington University in St Louis
Research Professor

CHRISTOPHER WEIGHT, MD, PhD

Cleveland Clinic Foundation
Center Director Urologic Oncology

VALISHA SHAH, MSc

Dana-Farber Cancer Institute
Computational Biologist

session 3

State of the Science

MODERATORS

ROHIT MEHRA, MD

University of Michigan
Clinical Professor of Pathology

PAYAL KAPUR, MD

University of Texas Southwestern Medical Center
Professor

SPEAKERS

SAMSON FINE, MD

Memorial Sloan Kettering Cancer Center
Pathologist

MICHELLE HIRSCH, MD, PhD

Brigham & Women’s Hospital, Harvard Medical School
Pathologist

PAYAL KAPUR, MD

University of Texas Southwestern Medical Center
Professor

ROHIT MEHRA, MD

University of Michigan
Clinical Professor of Pathology

SABINA SIGNORETTI, MD

Brigham & Women’s Hospital, Harvard Medical School
Associate Pathologist

special session 4

Trials in Progress

MODERATORS

NAOMI HAAS, MD

Abramson Cancer Center/University of Pennsylvania
Clinical Leader of Kidney Cancer Program

ROBERT MOTZER, MD

Memorial Sloan Kettering Cancer Center
Jack and Dorothy Byrne Chair in Clinical Oncology

speakers

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine and Urology

PAVLOS MSAOUEL, MD, PhD

MD Anderson Cancer Center
Assistant Professor

MICHAEL SERZAN, MD

Dana-Farber Cancer Institute
Medical Oncologist

GRANT STEWART, BSc, MBChB, PhD

University of Cambridge
Professor of Surgical Oncology

VINCENT XU, MD

Dana-Farber Cancer Institute
Assistant Professor of Medicine

kcrs24 day two

Obesity and Immunotherapy

FEATURED SPEAKER

JEFFREY RATHMELL, PhD

Vanderbilt University Medical Center
MPI Associate Director

session 5

Clinical and Scientific Updates in Kidney Cancer

MODERATOR

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

SPEAKERS

LAURENCE ALBIGES, MD, PhD

Institut Gustave-Roussy
Urology Committee Chairman

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

BRADLEY MCGREGOR, MD

Dana-Farber Cancer Institute
Director of Clinical Research, Lank Center for Genitourinary Oncology

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

ROBERT MOTZER, MD

Memorial Sloan Kettering Cancer Center
Jack and Dorothy Byrne Chair in Clinical Oncology

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Lead for Solid Tumour Research

session 6

Immunotherapy Advances and Research

MODERATORS

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

DAVID MCDERMOTT, MD

Beth Israel Deaconess Medical Center
Chief, Division of Medical Oncology

SPEAKERS

MICHAEL ATKINS, MD

Georgetown-Lombardi Comprehensive Cancer Center
Deputy Director

DAVID BRAUN, MD, PhD

Yale School of Medicine
Assistant Professor of Medicine

SRINIVAS MALLADI, PhD

University of Texas Southwestern Medical Center
Assistant Professor

JONATHAN POWELL, MD, PhD

Calico Labs
Interim Head of Development

RIZWAN ROMEE, MD

Dana-Farber Cancer Institute
Associate Professor

session 7

Oral Abstract Presentations

MODERATORS

RANA MCKAY, MD

University of California, San Diego
Associate Professor of Medicine

YUKSEL URUN, MD

Ankara University School of Medicine
Professor of Medicine

SPEAKERS

LAURENCE ALBIGES, MD, PhD

Institut Gustave-Roussy
Urology Committee Chairman

TONI CHOUEIRI, MD

Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

NAZLI DIZMAN, MD

MD Anderson Cancer Center
Fellow

BRADLEY MCGREGOR, MD

Dana-Farber Cancer Institute
Director of Clinical Research, Lank Center for Genitourinary Oncology

EDDY SAAD, MD

Dana-Farber Cancer Institute
Research Fellow

KARL SEMAAN, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

session 8

Rapid Abstract Presentations

MODERATORS

SUMANTA PAL, MD

City of Hope Comprehensive Cancer Center
Professor, Department of Medical Oncology & Therapeutics Research

EVITA SADIMIN, MD

City of Hope Comprehensive Cancer Center
Associate Clinical Professor

SPEAKERS

SHAHLA BARI, MD

Duke University
Assistant Professor

REGINA BARRAGAN-CARRILLO, MD

City of Hope Comprehensive Cancer Center
Postdoctoral Fellow

ROY ELIAS, MD

Johns Hopkins
Medical Oncology Fellow

CHINMAY JANI, MB, BS

Sylvester Comprehensive Cancer Center
Clinical Fellow

SOKI KASHIMA, MD, PhD

Yale School of Medicine
Postdoctoral Research Fellow

MISO KIM, MD, MS, PhD

Seoul National University Hospital
Clinical Associate Professor

VIVIEN MORITZ

Yale School of Medicine
Research Associate

NICHOLAS SALGIA

Roswell Park Comprehensive Cancer Center
MD-PhD Student

SAMER SALEM, MD

Brigham and Women’s Hospital
Postdoctoral Research Fellow

RENEE MARIA SALIBY, MD

Dana-Farber Cancer Institute
Postdoctoral Research Fellow

Special Session:
Biotech Showcase

MODERATORS

THOMAS POWLES, MBBS, MRCP, MD

Barts Cancer Centre
Director, Lead for Solid Tumour Research

HANS HAMMERS, MD, PhD

UT Southwestern Medical Center
Professor of Internal Medicine, Division of Hematology-Oncology

DIMITRY NUYTEN, MD, PhD

Arcus Biosciences
Chief Medical Officer

LEVI GRAY-RUPP, PhD

ArsenalBio
Senior Director, Immunology

LU GAN, MD, PhD

Scholar Rock
Vice President, Oncology Clinical Development

ALEX AZRILEVICH, PharmD

Synthekine
Vice President, Oncology Clinical Development

PAVLOS MSAOUEL, MD, PhD

BostonGene
MD Anderson Cancer Center
Assistant Professor

KIM ALLMAN, MSN

Telix
Medical Director

CHET BOHAC, MS

Xencor
Executive Medical Director